Halozyme Therapeutics, Inc. (BMV:HALO)
1,018.51
+9.74 (0.97%)
At close: Jun 5, 2025
6.75% (1Y)
Market Cap | 122.00B |
Revenue (ttm) | 22.16B |
Net Income (ttm) | 9.92B |
Shares Out | n/a |
EPS (ttm) | 76.83 |
PE Ratio | 12.30 |
Forward PE | 8.71 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 300 |
Average Volume | 821 |
Open | 1,018.51 |
Previous Close | 1,008.77 |
Day's Range | 1,018.51 - 1,018.51 |
52-Week Range | 954.15 - 1,025.00 |
Beta | n/a |
RSI | n/a |
Earnings Date | Aug 5, 2025 |